Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth

Christopher S. Williams, Angela P. Goldman, Hongmiao Sheng, Jason D. Morrow, Raymond N. DuBois

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Sulindac sulfide, a metabolite of the nonsteroidal antiinflammatory drug (NSAID) sulindac sulfoxide, is effective at reducing tumor burden in both familial adenomatous polyposis patients and in animals with colorectal cancer. Another sulindac sulfoxide metabolite, sulindac sulfone, has been reported to have antitumor properties without inhibiting cyclooxygenase activity. Here we report the effect of sulindac sulfone treatment on the growth of colorectal carcinoma cells. We observed that sulindac sulfide or sulfone treatment of HCA-7 cells led to inhibition of prostaglandin E2 production. Both sulindac sulfide and sulfone inhibited HCA-7 and HCT-116 cell growth in vitro. Sulindac sulfone had no effect on the growth of either HCA-7 or HCT-116 xenografts, whereas the sulfide derivative inhibited HCA-7 growth in vivo. Both sulindac sulfide and sulfone inhibited colon carcinoma cell growth and prostaglandin production in vitro, but sulindac sulfone had no effect on the growth of colon cancer cell xenografts in nude mice.

Original languageEnglish (US)
Pages (from-to)170-176
Number of pages7
JournalNeoplasia
Volume1
Issue number2
StatePublished - Jun 1999
Externally publishedYes

Fingerprint

Colorectal Neoplasms
sulfoxide
Growth
Sulindac
Heterografts
HCT116 Cells
Adenomatous Polyposis Coli
Sulfides
Prostaglandin-Endoperoxide Synthases
sulindac sulfide
sulindac sulfone
Tumor Burden
Dinoprostone
Nude Mice
Colonic Neoplasms
Prostaglandins
Colon
Anti-Inflammatory Agents
Carcinoma
Therapeutics

Keywords

  • Chemoprevention
  • Colorectal cancer
  • Sulindac
  • Sulindac sulfide
  • Sulindac sulfone

ASJC Scopus subject areas

  • Cancer Research

Cite this

Williams, C. S., Goldman, A. P., Sheng, H., Morrow, J. D., & DuBois, R. N. (1999). Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth. Neoplasia, 1(2), 170-176.

Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth. / Williams, Christopher S.; Goldman, Angela P.; Sheng, Hongmiao; Morrow, Jason D.; DuBois, Raymond N.

In: Neoplasia, Vol. 1, No. 2, 06.1999, p. 170-176.

Research output: Contribution to journalArticle

Williams, CS, Goldman, AP, Sheng, H, Morrow, JD & DuBois, RN 1999, 'Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth', Neoplasia, vol. 1, no. 2, pp. 170-176.
Williams CS, Goldman AP, Sheng H, Morrow JD, DuBois RN. Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth. Neoplasia. 1999 Jun;1(2):170-176.
Williams, Christopher S. ; Goldman, Angela P. ; Sheng, Hongmiao ; Morrow, Jason D. ; DuBois, Raymond N. / Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth. In: Neoplasia. 1999 ; Vol. 1, No. 2. pp. 170-176.
@article{9091508844a2413eba1da0b68951420e,
title = "Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth",
abstract = "Sulindac sulfide, a metabolite of the nonsteroidal antiinflammatory drug (NSAID) sulindac sulfoxide, is effective at reducing tumor burden in both familial adenomatous polyposis patients and in animals with colorectal cancer. Another sulindac sulfoxide metabolite, sulindac sulfone, has been reported to have antitumor properties without inhibiting cyclooxygenase activity. Here we report the effect of sulindac sulfone treatment on the growth of colorectal carcinoma cells. We observed that sulindac sulfide or sulfone treatment of HCA-7 cells led to inhibition of prostaglandin E2 production. Both sulindac sulfide and sulfone inhibited HCA-7 and HCT-116 cell growth in vitro. Sulindac sulfone had no effect on the growth of either HCA-7 or HCT-116 xenografts, whereas the sulfide derivative inhibited HCA-7 growth in vivo. Both sulindac sulfide and sulfone inhibited colon carcinoma cell growth and prostaglandin production in vitro, but sulindac sulfone had no effect on the growth of colon cancer cell xenografts in nude mice.",
keywords = "Chemoprevention, Colorectal cancer, Sulindac, Sulindac sulfide, Sulindac sulfone",
author = "Williams, {Christopher S.} and Goldman, {Angela P.} and Hongmiao Sheng and Morrow, {Jason D.} and DuBois, {Raymond N.}",
year = "1999",
month = "6",
language = "English (US)",
volume = "1",
pages = "170--176",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth

AU - Williams, Christopher S.

AU - Goldman, Angela P.

AU - Sheng, Hongmiao

AU - Morrow, Jason D.

AU - DuBois, Raymond N.

PY - 1999/6

Y1 - 1999/6

N2 - Sulindac sulfide, a metabolite of the nonsteroidal antiinflammatory drug (NSAID) sulindac sulfoxide, is effective at reducing tumor burden in both familial adenomatous polyposis patients and in animals with colorectal cancer. Another sulindac sulfoxide metabolite, sulindac sulfone, has been reported to have antitumor properties without inhibiting cyclooxygenase activity. Here we report the effect of sulindac sulfone treatment on the growth of colorectal carcinoma cells. We observed that sulindac sulfide or sulfone treatment of HCA-7 cells led to inhibition of prostaglandin E2 production. Both sulindac sulfide and sulfone inhibited HCA-7 and HCT-116 cell growth in vitro. Sulindac sulfone had no effect on the growth of either HCA-7 or HCT-116 xenografts, whereas the sulfide derivative inhibited HCA-7 growth in vivo. Both sulindac sulfide and sulfone inhibited colon carcinoma cell growth and prostaglandin production in vitro, but sulindac sulfone had no effect on the growth of colon cancer cell xenografts in nude mice.

AB - Sulindac sulfide, a metabolite of the nonsteroidal antiinflammatory drug (NSAID) sulindac sulfoxide, is effective at reducing tumor burden in both familial adenomatous polyposis patients and in animals with colorectal cancer. Another sulindac sulfoxide metabolite, sulindac sulfone, has been reported to have antitumor properties without inhibiting cyclooxygenase activity. Here we report the effect of sulindac sulfone treatment on the growth of colorectal carcinoma cells. We observed that sulindac sulfide or sulfone treatment of HCA-7 cells led to inhibition of prostaglandin E2 production. Both sulindac sulfide and sulfone inhibited HCA-7 and HCT-116 cell growth in vitro. Sulindac sulfone had no effect on the growth of either HCA-7 or HCT-116 xenografts, whereas the sulfide derivative inhibited HCA-7 growth in vivo. Both sulindac sulfide and sulfone inhibited colon carcinoma cell growth and prostaglandin production in vitro, but sulindac sulfone had no effect on the growth of colon cancer cell xenografts in nude mice.

KW - Chemoprevention

KW - Colorectal cancer

KW - Sulindac

KW - Sulindac sulfide

KW - Sulindac sulfone

UR - http://www.scopus.com/inward/record.url?scp=0033139531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033139531&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 170

EP - 176

JO - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 2

ER -